President Biden on Saturday announced new programs and funding for cancer surgery research as part of his administration's “Cancer Moonshot” initiative aimed at reducing cancer deaths.
“I'm proud that our four countries, the leaders behind me and many of the organizations here today are investing more than $150 million in HPV, HPV testing and treatment. Next year, we're launching a program where U.S. Navy doctors and nurses will train their colleagues in the Indo-Pacific region to administer cervical cancer screening and vaccinations, so that we can provide health care to every woman in this region, and that's important,” Biden said during a joint meeting and dinner with the leaders of Australia, Japan and India.
Biden invited members of the Quad, the United States, Australia, India and Japan Security Dialogue, to his home state of Delaware.
The president's son, Beau Biden, died of brain cancer in 2015. Biden began his speech by telling the story of how the president, who at the time noted was dying, promised Beau that he would stay involved in cancer research.
Last month, the president and first lady Jill Biden visited Louisiana to speak about how funding from the U.S. Department of Health's Advanced Research Projects Agency (ARPA-H) is being used to advance cancer treatment and discovery as part of the White House's Cancer Moonshot initiative.
The President relaunched the Moon Shots program in February 2022 with the goal of halving cancer deaths over the next 25 years and improving the lives of caregivers and cancer survivors.
Last year, the White House announced $240 million in ARPA-H funding to support researchers and innovators working on cancer-related projects to advance the Moon Shots program.
